Shopping Cart
- Remove All
- Your shopping cart is currently empty
MT-1207 is a selective antagonist of adrenergic α1 and 5-HT2A receptors with oral activity. It exhibits IC50 values of <0.1 nM for α1A, 0.15 nM for α1B, 1.40 nM for α1D, and 0.27 nM for 5-HT2A. In the 2K2C rat model, MT-1207 effectively reduces blood pressure (BP) without impairing renal function. As a multitarget inhibitor, MT-1207 has potential for research in vasodilation.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | MT-1207 is a selective antagonist of adrenergic α1 and 5-HT2A receptors with oral activity. It exhibits IC50 values of <0.1 nM for α1A, 0.15 nM for α1B, 1.40 nM for α1D, and 0.27 nM for 5-HT2A. In the 2K2C rat model, MT-1207 effectively reduces blood pressure (BP) without impairing renal function. As a multitarget inhibitor, MT-1207 has potential for research in vasodilation. |
Targets&IC50 | α1D-adrenergic receptor:0.69 nM (Ki), α1B-adrenergic receptor:1.40 nM (Ki), α1D-adrenergic receptor:0.086 nM, 5-HT 2A Receptor:0.27 nM, 5-HT 2A Receptor:0.079 nM (Ki), α1B-adrenergic receptor:0.15 nM, α1A-adrenergic receptor:0.1 nM |
Molecular Weight | 428.98 |
Formula | C21H25ClN6S |
Cas No. | 1610794-70-1 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.